InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Wednesday, 12/05/2018 5:28:32 PM

Wednesday, December 05, 2018 5:28:32 PM

Post# of 751
Rova-T phase-3 in second-line SCLC halted for futility:

https://www.prnewswire.com/news-releases/phase-3-trial-of-rova-t-as-second-line-therapy-for-advanced-small-cell-lung-cancer-tahoe-study-halted-300760918.html

An Independent Data Monitoring Committee (IDMC) recommended stopping enrollment in TAHOE due to shorter overall survival in the Rova-T arm compared with the topotecan control arm.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News